Dr. Brian Lawenda's article argues that cancer is a metabolic disease fueled by high blood sugar and insulin resistance. He explains the Warburg Effect, where cancer cells preferentially use glucose for energy, and how insulin resistance, often undiagnosed, creates a perfect environment for cancer growth. The article emphasizes the importance of achieving optimal metabolic health, including maintaining low blood sugar levels, which can be monitored using Continuous Glucose Monitors (CGMs). Lawenda details lifestyle changes, such as diet, exercise, and stress management, to reverse insulin resistance and reduce cancer risk. Ultimately, the piece stresses proactive health choices to prevent cancer development.